If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
312.00    0.00 (0.00%)
Bid:
310.00
Ask:
314.00
Spread: 4.00 (1.29%)
Market Cap: £39.59m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5104P
System1 Group PLC
20 January 2026
 

 

 

 

 

20 January 2026

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

Trading Update - Growth in Platform Revenue in Q3 over first two quarters-

FY26 guidance maintained

 

System1 www.system1group.com today issues an update on trading for the quarter ended 31 December 2025 ("Q3 FY26", "Q3").

 

Platform revenue in Q3 was higher than the preceding two quarters, benefiting from increased Adtesting revenue in the UK and Europe which in H1 experienced reduced, but ongoing, spend by many clients due to the wider macroeconomic uncertainty.

 

Platform revenue was in line with the previous record Q3 FY25, and grew by 1% against that Q3 FY25 in constant currency. US platform revenue was in line with H1, and momentum in Innovation Platform revenue continued.

 

Non-platform revenue was £0.4m lower than in Q3 FY25 resulting in a 4% fall in reported total Group revenue (3% at constant currency) compared with last year's record Q3.

 

Revenue from new client wins grew by 10% in the first nine months of FY26 compared with the same period in FY25. These new clients contributed £7.4m of the £25.7m Platform Revenue in the year to date, a third of it in the US, and provide significant opportunities for future growth.

 

The Group held net cash of £8.3m at the end of December (Dec 2024: £10.2m) following the £1.4m dividend payment in October.

 

The Board maintains the FY26 guidance1 it provided on 23 September 2025 and in the interim results on 2 December 2025.

 

 

 

 

Revenue £ million - unaudited

Q3

Q3

Q3

YTD

YTD

YTD

FY26

FY25

% YoY

FY26

FY25

% YoY

Predict Your (data)

8.1

8.2

-1%

21.5

21.5

0%

Improve Your (data-led consultancy)

1.4

1.3

8%

4.2

4.7

-11%

Platform Revenue

9.5

9.5

0%

25.7

26.2

-2%

Other consultancy (non-platform)

0.3

0.7

-57%

1.2

2.3

-48%

Total Revenue

9.8

10.2

-4%

26.9

28.5

-6%

 

Commenting on the trading update, CEO James Gregory said: "Q3 saw a recovery in our revenue, particularly in UK & Europe, with many of our largest clients' Adtesting spend normalising after a reduced H1, providing some momentum for Q4. We therefore remain confident in maintaining our guidance for the year."

 

Further information on the Company can be found at www.system1group.com.

 

1 For the purpose of this announcement, the guidance provided in the 23 September 2025 announcement was for FY26 Revenue to be broadly in line with the £37m achieved in FY25, and Adjusted Profit beforeTaxation2 in a range between £2.0 to £2.5 million.

2 Adjusted Profit is Profit before Taxation excluding share-based payments

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)7467 990147

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

 

Singer Capital Markets (Joint Broker)

Tel: +44 (0) 20 7496 3000 

James Moat / James Fischer / Sara Hale

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKSRRNKUAAUR
Date   Source Headline
12th Jan 202212:30 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.